Kopran Limited (BOM:524280)
India · Delayed Price · Currency is INR 271.00
-3.10 (-1.13%)
At close: Oct 16, 2026
Kopran Market Cap
Kopran has a market cap or net worth of 13.09 billion as of October 16, 2026. It is the 23,039th most valuable company in the world and the 1,468th biggest in India. Its market cap has increased by 61.31% in one year.
Market Cap
13.09B
Enterprise Value
14.61B
Revenue
7.00B
Global Rank
Country Rank
#1,468 India
PE Ratio
52.38
ChartMarket Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 13.09B, an increase of 2,187.66%. That is a compound annual growth rate of 13.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 13.09B | 80.79% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 21.95B |
| Syncom Formulations (India) | 20.60B |
| Amrutanjan Health Care | 14.82B |
| TTK Healthcare | 14.59B |
| Fermenta Biotech | 13.99B |
| Bharat Parenterals | 12.43B |
| Lincoln Pharmaceuticals | 10.95B |
| Sudarshan Pharma Industries | 9.26B |